MAESTrO: CADTH calls for patient input on a new submission from Janssen-Cilag for canagliflozin hemihydrate with metformin hydrochloride

Posted by Michael Wonder on 03 Feb 2016

CADTH calls for patient input on a new submission from Janssen-Cilag for canagliflozin hemihydrate with metformin hydrochloride

3 February 2016 - CADTH has received notice of a pending submission from Janssen-Cilag for canagliflozin hemihydrate with metformin hydrochloride for use by patients with type 2 diabetes mellitus.

For more details, go to: https://www.cadth.ca/canagliflozin-and-metformin-hydrochloride

Posted by:

Michael Wonder

Posted in:

Health technology assessment , Combination product , Canada , Type 2 diabetes mellitus